Brain Reward Function and Withdrawal from Nicotine and Methamphetamine in Rats
Author Information
Author(s): Miyata Hisatsugu, Itasaka Michio, Kimura Naofumi, Nakayama Kazuhiko
Primary Institution: Jikei University School of Medicine
Hypothesis
Does brain reward function decrease during withdrawal from nicotine and methamphetamine, and is this decrease related to aversion during withdrawal?
Conclusion
The study found that brain reward function decreases during withdrawal from nicotine and methamphetamine, which may reflect a negative affective state.
Supporting Evidence
- Chronic nicotine and methamphetamine infusion decreased ICSS reward thresholds.
- Mecamylamine and haloperidol increased ICSS reward thresholds during withdrawal.
- Place aversion was induced by mecamylamine and haloperidol in drug-infused rats.
- Somatic withdrawal signs were not significantly different between drug and saline-treated rats.
Takeaway
When rats stop using nicotine or methamphetamine, their brains feel less reward, which makes them feel bad.
Methodology
Male Sprague-Dawley rats were infused with nicotine or methamphetamine and tested using intracranial self-stimulation and conditioned place aversion paradigms.
Potential Biases
Potential bias in the interpretation of behavioral responses due to the subjective nature of the assessments.
Limitations
The study primarily used male rats, which may limit the generalizability of the findings to other populations.
Participant Demographics
Seventy-two male Sprague-Dawley rats, aged and weight range not specified.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website